Treatment of nausea in pregnancy: a cross-sectional multinational web-based study of pregnant women and new mothers

Kristine Heitmann, Lone Holst, Angela Lupattelli, Caroline Maltepe, Hedvig Nordeng, Kristine Heitmann, Lone Holst, Angela Lupattelli, Caroline Maltepe, Hedvig Nordeng

Abstract

Background: The factors related to the treatment of nausea during pregnancy have not yet been investigated in several countries simultaneously. The present study aimed to describe differences in self-reported nausea during pregnancy and the patterns of use for both conventional and herbal medicines across countries. The factors related to nausea and its treatment and the relationships between different self-reported co-morbidities and nausea were also investigated.

Methods: This cross-sectional study used data collected by a web-based questionnaire distributed between October 2011 and February 2012 in several countries within five regions: Western, Northern, and Eastern Europe, North America, and Australia. Women who were pregnant or had a child less than one year old were eligible to participate.

Results: A total of 9113 women were included in the study, whereof 6701 (73.5%) had experienced nausea during pregnancy. Among respondents with nausea, conventional medicines were used by 1201 (17.9%) women and herbal medicines by 556 (8.3%) women. The extent of self-reported nausea and its treatment varied by country. Education, working status, and folic acid use were significantly associated with the use of conventional medicines against nausea. Respondents who had nausea also had a high burden of co-morbidity.

Conclusion: The prevalence of nausea was high across all participating countries but its treatment varied, possibly due to cultural differences and differences in attitudes towards medicines. A high degree of co-morbidity was found among respondents with nausea.

Figures

Fig. 1
Fig. 1
Use of treatment against nausea among women experiencing nausea

References

    1. Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20:e171–183.
    1. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43:245–248.
    1. Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182:931–937. doi: 10.1016/S0002-9378(00)70349-8.
    1. Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol. 1985;66:612–616.
    1. Smith C, Crowther C, Beilby J, Dandeaux J. The impact of nausea and vomiting on women: a burden of early pregnancy. Aust N Z J Obstet Gynaecol. 2000;40:397–401. doi: 10.1111/j.1479-828X.2000.tb01167.x.
    1. Attard CL, Kohli MA, Coleman S, Bradley C, Hux M, Atanackovic G, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol. 2002;186:S220–227. doi: 10.1067/mob.2002.122605.
    1. Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol. 2000;21:129–136. doi: 10.3109/01674820009075620.
    1. O'Brien B, Evans M, White-McDonald E. Isolation from "being alive": coping with severe nausea and vomiting of pregnancy. Nurs Res. 2002;51:302–308. doi: 10.1097/00006199-200209000-00006.
    1. Chou FH, Lin LL, Cooney AT, Walker LO, Riggs MW. Psychosocial factors related to nausea, vomiting, and fatigue in early pregnancy. J Nurs Scholarsh. 2003;35:119–125. doi: 10.1111/j.1547-5069.2003.00119.x.
    1. Dorheim S, Bjorvatn B, Eberhard-Gran M. Sick leave during pregnancy: a longitudinal study of rates and risk factors in a Norwegian population. BJOG. 2013;120(5):521–30. doi: 10.1111/1471-0528.12035.
    1. Piwko C, Ungar WJ, Einarson TR, Wolpin J, Koren G. The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Curr Med Res Opin. 2007;23:833–840. doi: 10.1185/030079907X178739.
    1. Piwko C, Koren G, Babashov V, Vicente C, Einarson TR. Economic burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol. 2013;20:e149–160.
    1. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66:207–214. doi: 10.1007/s00228-009-0744-2.
    1. Einarson A, Koren G, Bergman U. Nausea and vomiting in pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol. 1998;76:1–3. doi: 10.1016/S0301-2115(97)00129-2.
    1. Lacasse A, Rey E, Ferreira E, Morin C, Berard A. Nausea and vomiting of pregnancy: what about quality of life? BJOG. 2008;115:1484–1493. doi: 10.1111/j.1471-0528.2008.01891.x.
    1. Heitmann K, Nordeng H, Holst L. Safety of ginger use in pregnancy: results from a large population-based cohort study. Eur J Clin Pharmacol. 2013;69:269–277. doi: 10.1007/s00228-012-1331-5.
    1. Asker C, Norstedt Wikner B, Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol. 2005;61:899–906. doi: 10.1007/s00228-005-0055-1.
    1. Hollyer T, Boon H, Georgousis A, Smith M, Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy. BMC Complement Altern Med. 2002;2:5. doi: 10.1186/1472-6882-2-5.
    1. Chandra K, Magee L, Einarson A, Koren G. Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. J Psychosom Obstet Gynaecol. 2003;24:71–75. doi: 10.3109/01674820309042804.
    1. Anderka M, Mitchell AA, Louik C, Werler MM, Hernandez-Diaz S, Rasmussen SA, et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94:22–30. doi: 10.1002/bdra.22865.
    1. van Gelder M, Pijpe A. E-epidemiology: a comprehensive update. Cancer. 2013;15:0.007.
    1. Huybrechts KF, Mikkelsen EM, Christensen T, Riis AH, Hatch EE, Wise LA, et al. A successful implementation of e-epidemiology: the Danish pregnancy planning study ‘Snart-Gravid’. Eur J Epidemiol. 2010;25:297–304. doi: 10.1007/s10654-010-9431-y.
    1. Lupattelli A, Spigset O, Twigg M, Zagorodnikova K, Mårdby A, Moretti M, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ open. 2014;4:e004365. doi: 10.1136/bmjopen-2013-004365.
    1. Martindale W, Sweetman SC. Martindale: the complete drug reference. London: Pharmaceutical Press; 2011.
    1. WHO Collaborating Centre for Drugs Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. . Accessed 19 March 2015.
    1. Kennedy DA, Lupattelli A, Koren G, Nordeng H. Herbal medicine use in pregnancy: results of a multinational study. BMC Complement Altern Med. 2013;13:355. doi: 10.1186/1472-6882-13-355.
    1. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–786. doi: 10.1192/bjp.150.6.782.
    1. Bergink V, Kooistra L, den Berg MP L-v, Wijnen H, Bunevicius R, van Baar A, et al. Validation of the Edinburgh Depression Scale during pregnancy. J Psychosom Res. 2011;70:385–389. doi: 10.1016/j.jpsychores.2010.07.008.
    1. Cox JL, Holden J. Perinatal mental health: a guide to the Edinburgh Postnatal Depression Scale (EPDS). RCPsych Publications;2003.
    1. Department of Health . Edinburgh Postnatal Depression Scale (EPDS): Translated versions – validated. Perth, Western Australia: State Perinatal Mental Health Reference Group. Government of Western Australia; 2006.
    1. Grote V, Vik T, von Kries R, Luque V, Socha J, Verduci E, et al. Maternal postnatal depression and child growth: a European cohort study. BMC pediatrics. 2010;10:14. doi: 10.1186/1471-2431-10-14.
    1. Stewart DE, Gagnon A, Saucier JF, Wahoush O, Dougherty G. Postpartum depression symptoms in newcomers. Can J Psychiatry. 2008;53:121–124.
    1. Tamminen T. Postnatal depression, breastfeeding and mother-infant interaction. Unpublished doctoral thesis. Tampere, Finland: University of Tampere; 1990.
    1. Gadsby R, Barnie-Adshead T, Sykes C. Why won't doctors prescribe antiemetics in pregnancy? BMJ. 2011;343:d4387. doi: 10.1136/bmj.d4387.
    1. Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G. The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod Toxicol. 1999;13:313–319. doi: 10.1016/S0890-6238(99)00018-0.
    1. Maltepe C, Koren G. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum--a 2013 update. J Popul Ther Clin Pharmacol. 2013;20:e184–192.
    1. Arsenault MY, Lane CA, MacKinnon CJ, Bartellas E, Cargill YM, Klein MC, et al. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can. 2002;24:817–831.
    1. De Vigan C, De Walle HEK, Cordier S, Goujard J, Knill-Jones R, Ayme S, et al. Therapeutic drug use during pregnancy: A comparison in four European countries. J Clin Epidemiol. 1999;52:977–982. doi: 10.1016/S0895-4356(99)00091-8.
    1. Goodwin TM, Poursharif B, Korst LM, MacGibbon KW, Romero R, Fejzo MS. Secular trends in the treatment of hyperemesis gravidarum. Am J Perinatol. 2008;25(3):141–7. doi: 10.1055/s-2008-1040344.
    1. Seto A, Einarson T, Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol. 1997;14:119–124. doi: 10.1055/s-2007-994110.
    1. Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neona. 2002;11:146–152. doi: 10.1080/jmf.11.3.146.152.
    1. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA. 2013;310:1601–1611. doi: 10.1001/jama.2013.278343.
    1. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. New Engl J Med. 2009;360:2528–2535. doi: 10.1056/NEJMoa0807154.
    1. Smith J, Refuerzo J, Ramin S. Treatment and outcome of nausea and vomiting of pregnancy. UpToDate. 2014.
    1. National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. . Accessed 19 March 2015.
    1. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin No. 153: Nausea and vomiting of pregnancy. Obstet Gynecol. 2015; 126(3):e12-24.
    1. Koren G. Scary Science: Ondansetron Safety in Pregnancy-Two Opposing Results From the Same Danish Registry. Therapeutic drug monitoring 2014. [Epub ahead of print].
    1. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. . Accessed 19 March 2015.
    1. FDA. Drug safety communication: Abnormal heart rythms may be associated with use of Zofran (ondansetron). . Accessed 19 March 2015.
    1. Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. The New England journal of medicine. 2013;368:814–823. doi: 10.1056/NEJMoa1211035.
    1. Andersen JT, Jimenez-Solem E, Andersen NL, Poulsen HE. Ondansetron use in early pregnancy and the risk of congenital malformations-a register based nationwide cohort study. Pharmacoepidemiol Drug Saf. 2013;22:13–14.
    1. Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006;6:21. doi: 10.1186/1471-2393-6-21.
    1. Frawley J, Adams J, Sibbritt D, Steel A, Broom A, Gallois C. Prevalence and determinants of complementary and alternative medicine use during pregnancy: results from a nationally representative sample of Australian pregnant women. Aust N Z J Obstet Gynaecol. 2013;53:347–352. doi: 10.1111/ajo.12056.
    1. Dante G, Pedrielli G, Annessi E, Facchinetti F. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Matern Fetal Neonatal Med. 2013;26:306–312. doi: 10.3109/14767058.2012.722732.
    1. Kraft K. Artichoke leaf extract - Recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. Phytomedicine. 1997;4:369–378. doi: 10.1016/S0944-7113(97)80049-9.
    1. Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA. Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr Perinat Epidemiol. 2006;20:270–278. doi: 10.1111/j.1365-3016.2006.00723.x.
    1. Kallen B, Lundberg G, Aberg A. Relationship between vitamin use, smoking, and nausea and vomiting of pregnancy. Acta obstetricia et gynecologica Scandinavica. 2003;82:916–920. doi: 10.1034/j.1600-0412.2003.00307.x.
    1. Weigel MM, Weigel RM. The association of reproductive history, demographic factors, and alcohol and tobacco consumption with the risk of developing nausea and vomiting in early pregnancy. Am J Epidemiol. 1988;127:562–570.
    1. Emelianova S, Mazzotta P, Einarson A, Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clinical and investigative medicine Medecine clinique et experimentale. 1999;22:106–110.
    1. Kramer J, Bowen A, Stewart N, Muhajarine N. Nausea and vomiting of pregnancy: prevalence, severity and relation to psychosocial health. MCN Am J Matern Child Nurs. 2013;38:21–27. doi: 10.1097/NMC.0b013e3182748489.
    1. Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol. 2009;23:270.
    1. Gill SK, Maltepe C, Mastali K, Koren G. The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy. Obstet Gynecol Int. 2009;2009:585269. doi: 10.1155/2009/585269.
    1. Ekman A, Dickman PW, Klint A, Weiderpass E, Litton JE. Feasibility of using web-based questionnaires in large population-based epidemiological studies. Eur J Epidemiol. 2006;21:103–111. doi: 10.1007/s10654-005-6030-4.
    1. van Gelder MM, Bretveld RW, Roeleveld N. Web-based questionnaires: the future in epidemiology? Am J Epidemiol. 2010;172:1292–1298. doi: 10.1093/aje/kwq291.
    1. Seybert H. Internet use in households and by individuals in 2011. . Accessed 19 March 2015.
    1. Internet World Stats. Usage and population statistics. 2012. Available from: . Accessed 19 March 2015.
    1. United States Census Bureau. The 2012 Statistical Abstract. Information & Communications; 2010. Available from: . Accessed 19 March 2015.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe